MAPT and type 2 diabetes mellitus: Dysfunction in insulin signaling among individuals with T2DM can lead to the overactivation of glycogen synthase kinase-3, resulting in elevated tau phosphorylation, modifications of tau, and the degeneration of neurofibrils.